Rock Springs Capital Management’s Allergan plc AGN.PRA Stock Holding History

Rock Springs Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,000	Closed	-$2.93M	–	165
2017 Q4	$2.93M	Hold	5,000	–	–	0.13%	125
2017 Q3	$3.79M	Hold	5,000	–	–	0.17%	112
2017 Q2	$4.34M	Hold	5,000	–	–	0.22%	103
2017 Q1	$4.24M	Hold	5,000	–	–	0.24%	96
2016 Q4	$3.82M	Hold	5,000	–	–	0.26%	87
2016 Q3	$4.11M	Hold	5,000	–	–	0.26%	97
2016 Q2	$4.16M	Hold	5,000	–	–	0.31%	89
2016 Q1	$4.58M	Hold	5,000	–	–	0.38%	81
2015 Q4	$5.14M	Hold	5,000	–	–	0.39%	84
2015 Q3	$4.73M	Hold	5,000	–	–	0.38%	85
2015 Q2	$5.23M	Buy	+5,000	New	+$5.23M	0.38%	85

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

Rock Springs Capital Management's AGN.PRA Position: Q1 2018 in Review

Rock Springs Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 5,000 shares — an estimated $2.93M sold.

Rock Springs Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $5.23M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Rock Springs Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Rock Springs Capital Management sold 5,000 Allergan plc shares in Q1 2018, an estimated $2.93M.
Rock Springs Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
Rock Springs Capital Management's Allergan plc position peaked at $5.23M in Q2 2015.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Rock Springs Capital Management's 13F filing for Q1 2018, filed 15 May 2018.